Global Nonalcoholic Steatohepatitis (NASH) Market Growth (Status and Outlook) 2024-2030
The report requires updating with new data and is sent in 48 hours after order is placed.
According to our LPI (LP Information) latest study, the global Nonalcoholic Steatohepatitis (NASH) market size was valued at US$ 2997.6 million in 2023. With growing demand in downstream market, the Nonalcoholic Steatohepatitis (NASH) is forecast to a readjusted size of US$ 47610 million by 2030 with a CAGR of 48.4% during review period.
The research report highlights the growth potential of the global Nonalcoholic Steatohepatitis (NASH) market. Nonalcoholic Steatohepatitis (NASH) are expected to show stable growth in the future market. However, product differentiation, reducing costs, and supply chain optimization remain crucial for the widespread adoption of Nonalcoholic Steatohepatitis (NASH). Market players need to invest in research and development, forge strategic partnerships, and align their offerings with evolving consumer preferences to capitalize on the immense opportunities presented by the Nonalcoholic Steatohepatitis (NASH) market.
Non-alcoholic steatohepatitis (NASH), is one of the common liver diseases, often called silent liver disease. The major feature in NASH is fat deposition in the liver, along with inflammation.
Non-alcoholic drinks, also known as mocktails or alcohol-free beverages, are beverages that do not contain any alcohol. These drinks are a popular choice for those who do not consume alcohol, including designated drivers, people who are underage, or individuals who wish to avoid alcohol for personal or health reasons. There are a wide variety of non-alcoholic drinks available, ranging from soft drinks to fresh juices, herbal infusions, and specialty mocktails. Some examples of non-alcoholic drinks include: 1. Soft Drinks: This category includes popular carbonated beverages like cola, lemon-lime sodas, ginger ale, and root beer. These drinks are often sweet and fizzy, providing a refreshing and enjoyable beverage option. 2. Fruit Juices: Freshly squeezed or packaged fruit juices, such as orange, apple, grapefruit, pineapple, or cranberry juice, are a common choice. These juices offer a natural and flavorful alternative to alcoholic beverages. 3. Smoothies: Made from a blend of fruits, vegetables, yogurt, and other ingredients, smoothies provide a nutritious and wholesome non-alcoholic option. They can be customized with various flavors and ingredients to suit individual preferences. 4. Herbal Infusions and Tea: Herbal teas and infusions, such as chamomile, peppermint, green tea, or hibiscus tea, are popular choices. These beverages are caffeine-free and often have relaxing or soothing properties. 5. Mocktails: These are non-alcoholic cocktails that mimic the flavors and presentation of traditional cocktails. They are typically made with a combination of juices, sodas, and garnishes, providing a fancy and enjoyable experience without the alcohol. 6. Sparkling Water: Carbonated water or mineral water with added flavors or fruit infusions is a refreshing and hydrating option. It is often consumed plain or mixed with juices or syrups. These non-alcoholic drinks offer a variety of flavors, textures, and options for those who prefer not to consume alcohol. They are a great way to enjoy a beverage while socializing or relaxing without the effects of alcohol.
Key Features:
The report on Nonalcoholic Steatohepatitis (NASH) market reflects various aspects and provide valuable insights into the industry.
Market Size and Growth: The research report provide an overview of the current size and growth of the Nonalcoholic Steatohepatitis (NASH) market. It may include historical data, market segmentation by Type (e.g., Obeticholic acid?OCA?, Selonsertib), and regional breakdowns.
Market Drivers and Challenges: The report can identify and analyse the factors driving the growth of the Nonalcoholic Steatohepatitis (NASH) market, such as government regulations, environmental concerns, technological advancements, and changing consumer preferences. It can also highlight the challenges faced by the industry, including infrastructure limitations, range anxiety, and high upfront costs.
Competitive Landscape: The research report provides analysis of the competitive landscape within the Nonalcoholic Steatohepatitis (NASH) market. It includes profiles of key players, their market share, strategies, and product offerings. The report can also highlight emerging players and their potential impact on the market.
Technological Developments: The research report can delve into the latest technological developments in the Nonalcoholic Steatohepatitis (NASH) industry. This include advancements in Nonalcoholic Steatohepatitis (NASH) technology, Nonalcoholic Steatohepatitis (NASH) new entrants, Nonalcoholic Steatohepatitis (NASH) new investment, and other innovations that are shaping the future of Nonalcoholic Steatohepatitis (NASH).
Downstream Procumbent Preference: The report can shed light on customer procumbent behaviour and adoption trends in the Nonalcoholic Steatohepatitis (NASH) market. It includes factors influencing customer ' purchasing decisions, preferences for Nonalcoholic Steatohepatitis (NASH) product.
Government Policies and Incentives: The research report analyse the impact of government policies and incentives on the Nonalcoholic Steatohepatitis (NASH) market. This may include an assessment of regulatory frameworks, subsidies, tax incentives, and other measures aimed at promoting Nonalcoholic Steatohepatitis (NASH) market. The report also evaluates the effectiveness of these policies in driving market growth.
Environmental Impact and Sustainability: The research report assess the environmental impact and sustainability aspects of the Nonalcoholic Steatohepatitis (NASH) market.
Market Forecasts and Future Outlook: Based on the analysis conducted, the research report provide market forecasts and outlook for the Nonalcoholic Steatohepatitis (NASH) industry. This includes projections of market size, growth rates, regional trends, and predictions on technological advancements and policy developments.
Recommendations and Opportunities: The report conclude with recommendations for industry stakeholders, policymakers, and investors. It highlights potential opportunities for market players to capitalize on emerging trends, overcome challenges, and contribute to the growth and development of the Nonalcoholic Steatohepatitis (NASH) market.
Market Segmentation:
Nonalcoholic Steatohepatitis (NASH) market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of value.
Segmentation by type
According to our LPI (LP Information) latest study, the global Nonalcoholic Steatohepatitis (NASH) market size was valued at US$ 2997.6 million in 2023. With growing demand in downstream market, the Nonalcoholic Steatohepatitis (NASH) is forecast to a readjusted size of US$ 47610 million by 2030 with a CAGR of 48.4% during review period.
The research report highlights the growth potential of the global Nonalcoholic Steatohepatitis (NASH) market. Nonalcoholic Steatohepatitis (NASH) are expected to show stable growth in the future market. However, product differentiation, reducing costs, and supply chain optimization remain crucial for the widespread adoption of Nonalcoholic Steatohepatitis (NASH). Market players need to invest in research and development, forge strategic partnerships, and align their offerings with evolving consumer preferences to capitalize on the immense opportunities presented by the Nonalcoholic Steatohepatitis (NASH) market.
Non-alcoholic steatohepatitis (NASH), is one of the common liver diseases, often called silent liver disease. The major feature in NASH is fat deposition in the liver, along with inflammation.
Non-alcoholic drinks, also known as mocktails or alcohol-free beverages, are beverages that do not contain any alcohol. These drinks are a popular choice for those who do not consume alcohol, including designated drivers, people who are underage, or individuals who wish to avoid alcohol for personal or health reasons. There are a wide variety of non-alcoholic drinks available, ranging from soft drinks to fresh juices, herbal infusions, and specialty mocktails. Some examples of non-alcoholic drinks include: 1. Soft Drinks: This category includes popular carbonated beverages like cola, lemon-lime sodas, ginger ale, and root beer. These drinks are often sweet and fizzy, providing a refreshing and enjoyable beverage option. 2. Fruit Juices: Freshly squeezed or packaged fruit juices, such as orange, apple, grapefruit, pineapple, or cranberry juice, are a common choice. These juices offer a natural and flavorful alternative to alcoholic beverages. 3. Smoothies: Made from a blend of fruits, vegetables, yogurt, and other ingredients, smoothies provide a nutritious and wholesome non-alcoholic option. They can be customized with various flavors and ingredients to suit individual preferences. 4. Herbal Infusions and Tea: Herbal teas and infusions, such as chamomile, peppermint, green tea, or hibiscus tea, are popular choices. These beverages are caffeine-free and often have relaxing or soothing properties. 5. Mocktails: These are non-alcoholic cocktails that mimic the flavors and presentation of traditional cocktails. They are typically made with a combination of juices, sodas, and garnishes, providing a fancy and enjoyable experience without the alcohol. 6. Sparkling Water: Carbonated water or mineral water with added flavors or fruit infusions is a refreshing and hydrating option. It is often consumed plain or mixed with juices or syrups. These non-alcoholic drinks offer a variety of flavors, textures, and options for those who prefer not to consume alcohol. They are a great way to enjoy a beverage while socializing or relaxing without the effects of alcohol.
Key Features:
The report on Nonalcoholic Steatohepatitis (NASH) market reflects various aspects and provide valuable insights into the industry.
Market Size and Growth: The research report provide an overview of the current size and growth of the Nonalcoholic Steatohepatitis (NASH) market. It may include historical data, market segmentation by Type (e.g., Obeticholic acid?OCA?, Selonsertib), and regional breakdowns.
Market Drivers and Challenges: The report can identify and analyse the factors driving the growth of the Nonalcoholic Steatohepatitis (NASH) market, such as government regulations, environmental concerns, technological advancements, and changing consumer preferences. It can also highlight the challenges faced by the industry, including infrastructure limitations, range anxiety, and high upfront costs.
Competitive Landscape: The research report provides analysis of the competitive landscape within the Nonalcoholic Steatohepatitis (NASH) market. It includes profiles of key players, their market share, strategies, and product offerings. The report can also highlight emerging players and their potential impact on the market.
Technological Developments: The research report can delve into the latest technological developments in the Nonalcoholic Steatohepatitis (NASH) industry. This include advancements in Nonalcoholic Steatohepatitis (NASH) technology, Nonalcoholic Steatohepatitis (NASH) new entrants, Nonalcoholic Steatohepatitis (NASH) new investment, and other innovations that are shaping the future of Nonalcoholic Steatohepatitis (NASH).
Downstream Procumbent Preference: The report can shed light on customer procumbent behaviour and adoption trends in the Nonalcoholic Steatohepatitis (NASH) market. It includes factors influencing customer ' purchasing decisions, preferences for Nonalcoholic Steatohepatitis (NASH) product.
Government Policies and Incentives: The research report analyse the impact of government policies and incentives on the Nonalcoholic Steatohepatitis (NASH) market. This may include an assessment of regulatory frameworks, subsidies, tax incentives, and other measures aimed at promoting Nonalcoholic Steatohepatitis (NASH) market. The report also evaluates the effectiveness of these policies in driving market growth.
Environmental Impact and Sustainability: The research report assess the environmental impact and sustainability aspects of the Nonalcoholic Steatohepatitis (NASH) market.
Market Forecasts and Future Outlook: Based on the analysis conducted, the research report provide market forecasts and outlook for the Nonalcoholic Steatohepatitis (NASH) industry. This includes projections of market size, growth rates, regional trends, and predictions on technological advancements and policy developments.
Recommendations and Opportunities: The report conclude with recommendations for industry stakeholders, policymakers, and investors. It highlights potential opportunities for market players to capitalize on emerging trends, overcome challenges, and contribute to the growth and development of the Nonalcoholic Steatohepatitis (NASH) market.
Market Segmentation:
Nonalcoholic Steatohepatitis (NASH) market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of value.
Segmentation by type
- Obeticholic acid?OCA?
- Selonsertib
- Hospital Pharmacy
- Online Provider
- Retail Pharmacy
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- AstraZeneca
- Arena Pharmaceuticals
- GSK
- Novo Nordisk
- Roche
- Vivus
- Arisaph Pharmaceuticals
- Cempra Pharmaceuticals
- Galectin Therapeutics
- Galmed Pharmaceuticals
- Genfit
- Gilead
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Nonalcoholic Steatohepatitis (NASH) Market Size 2019-2030
2.1.2 Nonalcoholic Steatohepatitis (NASH) Market Size CAGR by Region 2019 VS 2023 VS 2030
2.2 Nonalcoholic Steatohepatitis (NASH) Segment by Type
2.2.1 Obeticholic acid?OCA?
2.2.2 Selonsertib
2.3 Nonalcoholic Steatohepatitis (NASH) Market Size by Type
2.3.1 Nonalcoholic Steatohepatitis (NASH) Market Size CAGR by Type (2019 VS 2023 VS 2030)
2.3.2 Global Nonalcoholic Steatohepatitis (NASH) Market Size Market Share by Type (2019-2024)
2.4 Nonalcoholic Steatohepatitis (NASH) Segment by Application
2.4.1 Hospital Pharmacy
2.4.2 Online Provider
2.4.3 Retail Pharmacy
2.5 Nonalcoholic Steatohepatitis (NASH) Market Size by Application
2.5.1 Nonalcoholic Steatohepatitis (NASH) Market Size CAGR by Application (2019 VS 2023 VS 2030)
2.5.2 Global Nonalcoholic Steatohepatitis (NASH) Market Size Market Share by Application (2019-2024)
3 NONALCOHOLIC STEATOHEPATITIS (NASH) MARKET SIZE BY PLAYER
3.1 Nonalcoholic Steatohepatitis (NASH) Market Size Market Share by Players
3.1.1 Global Nonalcoholic Steatohepatitis (NASH) Revenue by Players (2019-2024)
3.1.2 Global Nonalcoholic Steatohepatitis (NASH) Revenue Market Share by Players (2019-2024)
3.2 Global Nonalcoholic Steatohepatitis (NASH) Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2022-2024)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 NONALCOHOLIC STEATOHEPATITIS (NASH) BY REGIONS
4.1 Nonalcoholic Steatohepatitis (NASH) Market Size by Regions (2019-2024)
4.2 Americas Nonalcoholic Steatohepatitis (NASH) Market Size Growth (2019-2024)
4.3 APAC Nonalcoholic Steatohepatitis (NASH) Market Size Growth (2019-2024)
4.4 Europe Nonalcoholic Steatohepatitis (NASH) Market Size Growth (2019-2024)
4.5 Middle East & Africa Nonalcoholic Steatohepatitis (NASH) Market Size Growth (2019-2024)
5 AMERICAS
5.1 Americas Nonalcoholic Steatohepatitis (NASH) Market Size by Country (2019-2024)
5.2 Americas Nonalcoholic Steatohepatitis (NASH) Market Size by Type (2019-2024)
5.3 Americas Nonalcoholic Steatohepatitis (NASH) Market Size by Application (2019-2024)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Nonalcoholic Steatohepatitis (NASH) Market Size by Region (2019-2024)
6.2 APAC Nonalcoholic Steatohepatitis (NASH) Market Size by Type (2019-2024)
6.3 APAC Nonalcoholic Steatohepatitis (NASH) Market Size by Application (2019-2024)
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 EUROPE
7.1 Europe Nonalcoholic Steatohepatitis (NASH) by Country (2019-2024)
7.2 Europe Nonalcoholic Steatohepatitis (NASH) Market Size by Type (2019-2024)
7.3 Europe Nonalcoholic Steatohepatitis (NASH) Market Size by Application (2019-2024)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Nonalcoholic Steatohepatitis (NASH) by Region (2019-2024)
8.2 Middle East & Africa Nonalcoholic Steatohepatitis (NASH) Market Size by Type (2019-2024)
8.3 Middle East & Africa Nonalcoholic Steatohepatitis (NASH) Market Size by Application (2019-2024)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 GLOBAL NONALCOHOLIC STEATOHEPATITIS (NASH) MARKET FORECAST
10.1 Global Nonalcoholic Steatohepatitis (NASH) Forecast by Regions (2025-2030)
10.1.1 Global Nonalcoholic Steatohepatitis (NASH) Forecast by Regions (2025-2030)
10.1.2 Americas Nonalcoholic Steatohepatitis (NASH) Forecast
10.1.3 APAC Nonalcoholic Steatohepatitis (NASH) Forecast
10.1.4 Europe Nonalcoholic Steatohepatitis (NASH) Forecast
10.1.5 Middle East & Africa Nonalcoholic Steatohepatitis (NASH) Forecast
10.2 Americas Nonalcoholic Steatohepatitis (NASH) Forecast by Country (2025-2030)
10.2.1 United States Nonalcoholic Steatohepatitis (NASH) Market Forecast
10.2.2 Canada Nonalcoholic Steatohepatitis (NASH) Market Forecast
10.2.3 Mexico Nonalcoholic Steatohepatitis (NASH) Market Forecast
10.2.4 Brazil Nonalcoholic Steatohepatitis (NASH) Market Forecast
10.3 APAC Nonalcoholic Steatohepatitis (NASH) Forecast by Region (2025-2030)
10.3.1 China Nonalcoholic Steatohepatitis (NASH) Market Forecast
10.3.2 Japan Nonalcoholic Steatohepatitis (NASH) Market Forecast
10.3.3 Korea Nonalcoholic Steatohepatitis (NASH) Market Forecast
10.3.4 Southeast Asia Nonalcoholic Steatohepatitis (NASH) Market Forecast
10.3.5 India Nonalcoholic Steatohepatitis (NASH) Market Forecast
10.3.6 Australia Nonalcoholic Steatohepatitis (NASH) Market Forecast
10.4 Europe Nonalcoholic Steatohepatitis (NASH) Forecast by Country (2025-2030)
10.4.1 Germany Nonalcoholic Steatohepatitis (NASH) Market Forecast
10.4.2 France Nonalcoholic Steatohepatitis (NASH) Market Forecast
10.4.3 UK Nonalcoholic Steatohepatitis (NASH) Market Forecast
10.4.4 Italy Nonalcoholic Steatohepatitis (NASH) Market Forecast
10.4.5 Russia Nonalcoholic Steatohepatitis (NASH) Market Forecast
10.5 Middle East & Africa Nonalcoholic Steatohepatitis (NASH) Forecast by Region (2025-2030)
10.5.1 Egypt Nonalcoholic Steatohepatitis (NASH) Market Forecast
10.5.2 South Africa Nonalcoholic Steatohepatitis (NASH) Market Forecast
10.5.3 Israel Nonalcoholic Steatohepatitis (NASH) Market Forecast
10.5.4 Turkey Nonalcoholic Steatohepatitis (NASH) Market Forecast
10.5.5 GCC Countries Nonalcoholic Steatohepatitis (NASH) Market Forecast
10.6 Global Nonalcoholic Steatohepatitis (NASH) Forecast by Type (2025-2030)
10.7 Global Nonalcoholic Steatohepatitis (NASH) Forecast by Application (2025-2030)
11 KEY PLAYERS ANALYSIS
11.1 AstraZeneca
11.1.1 AstraZeneca Company Information
11.1.2 AstraZeneca Nonalcoholic Steatohepatitis (NASH) Product Offered
11.1.3 AstraZeneca Nonalcoholic Steatohepatitis (NASH) Revenue, Gross Margin and Market Share (2019-2024)
11.1.4 AstraZeneca Main Business Overview
11.1.5 AstraZeneca Latest Developments
11.2 Arena Pharmaceuticals
11.2.1 Arena Pharmaceuticals Company Information
11.2.2 Arena Pharmaceuticals Nonalcoholic Steatohepatitis (NASH) Product Offered
11.2.3 Arena Pharmaceuticals Nonalcoholic Steatohepatitis (NASH) Revenue, Gross Margin and Market Share (2019-2024)
11.2.4 Arena Pharmaceuticals Main Business Overview
11.2.5 Arena Pharmaceuticals Latest Developments
11.3 GSK
11.3.1 GSK Company Information
11.3.2 GSK Nonalcoholic Steatohepatitis (NASH) Product Offered
11.3.3 GSK Nonalcoholic Steatohepatitis (NASH) Revenue, Gross Margin and Market Share (2019-2024)
11.3.4 GSK Main Business Overview
11.3.5 GSK Latest Developments
11.4 Novo Nordisk
11.4.1 Novo Nordisk Company Information
11.4.2 Novo Nordisk Nonalcoholic Steatohepatitis (NASH) Product Offered
11.4.3 Novo Nordisk Nonalcoholic Steatohepatitis (NASH) Revenue, Gross Margin and Market Share (2019-2024)
11.4.4 Novo Nordisk Main Business Overview
11.4.5 Novo Nordisk Latest Developments
11.5 Roche
11.5.1 Roche Company Information
11.5.2 Roche Nonalcoholic Steatohepatitis (NASH) Product Offered
11.5.3 Roche Nonalcoholic Steatohepatitis (NASH) Revenue, Gross Margin and Market Share (2019-2024)
11.5.4 Roche Main Business Overview
11.5.5 Roche Latest Developments
11.6 Vivus
11.6.1 Vivus Company Information
11.6.2 Vivus Nonalcoholic Steatohepatitis (NASH) Product Offered
11.6.3 Vivus Nonalcoholic Steatohepatitis (NASH) Revenue, Gross Margin and Market Share (2019-2024)
11.6.4 Vivus Main Business Overview
11.6.5 Vivus Latest Developments
11.7 Arisaph Pharmaceuticals
11.7.1 Arisaph Pharmaceuticals Company Information
11.7.2 Arisaph Pharmaceuticals Nonalcoholic Steatohepatitis (NASH) Product Offered
11.7.3 Arisaph Pharmaceuticals Nonalcoholic Steatohepatitis (NASH) Revenue, Gross Margin and Market Share (2019-2024)
11.7.4 Arisaph Pharmaceuticals Main Business Overview
11.7.5 Arisaph Pharmaceuticals Latest Developments
11.8 Cempra Pharmaceuticals
11.8.1 Cempra Pharmaceuticals Company Information
11.8.2 Cempra Pharmaceuticals Nonalcoholic Steatohepatitis (NASH) Product Offered
11.8.3 Cempra Pharmaceuticals Nonalcoholic Steatohepatitis (NASH) Revenue, Gross Margin and Market Share (2019-2024)
11.8.4 Cempra Pharmaceuticals Main Business Overview
11.8.5 Cempra Pharmaceuticals Latest Developments
11.9 Galectin Therapeutics
11.9.1 Galectin Therapeutics Company Information
11.9.2 Galectin Therapeutics Nonalcoholic Steatohepatitis (NASH) Product Offered
11.9.3 Galectin Therapeutics Nonalcoholic Steatohepatitis (NASH) Revenue, Gross Margin and Market Share (2019-2024)
11.9.4 Galectin Therapeutics Main Business Overview
11.9.5 Galectin Therapeutics Latest Developments
11.10 Galmed Pharmaceuticals
11.10.1 Galmed Pharmaceuticals Company Information
11.10.2 Galmed Pharmaceuticals Nonalcoholic Steatohepatitis (NASH) Product Offered
11.10.3 Galmed Pharmaceuticals Nonalcoholic Steatohepatitis (NASH) Revenue, Gross Margin and Market Share (2019-2024)
11.10.4 Galmed Pharmaceuticals Main Business Overview
11.10.5 Galmed Pharmaceuticals Latest Developments
11.11 Genfit
11.11.1 Genfit Company Information
11.11.2 Genfit Nonalcoholic Steatohepatitis (NASH) Product Offered
11.11.3 Genfit Nonalcoholic Steatohepatitis (NASH) Revenue, Gross Margin and Market Share (2019-2024)
11.11.4 Genfit Main Business Overview
11.11.5 Genfit Latest Developments
11.12 Gilead
11.12.1 Gilead Company Information
11.12.2 Gilead Nonalcoholic Steatohepatitis (NASH) Product Offered
11.12.3 Gilead Nonalcoholic Steatohepatitis (NASH) Revenue, Gross Margin and Market Share (2019-2024)
11.12.4 Gilead Main Business Overview
11.12.5 Gilead Latest Developments
12 RESEARCH FINDINGS AND CONCLUSION
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Nonalcoholic Steatohepatitis (NASH) Market Size 2019-2030
2.1.2 Nonalcoholic Steatohepatitis (NASH) Market Size CAGR by Region 2019 VS 2023 VS 2030
2.2 Nonalcoholic Steatohepatitis (NASH) Segment by Type
2.2.1 Obeticholic acid?OCA?
2.2.2 Selonsertib
2.3 Nonalcoholic Steatohepatitis (NASH) Market Size by Type
2.3.1 Nonalcoholic Steatohepatitis (NASH) Market Size CAGR by Type (2019 VS 2023 VS 2030)
2.3.2 Global Nonalcoholic Steatohepatitis (NASH) Market Size Market Share by Type (2019-2024)
2.4 Nonalcoholic Steatohepatitis (NASH) Segment by Application
2.4.1 Hospital Pharmacy
2.4.2 Online Provider
2.4.3 Retail Pharmacy
2.5 Nonalcoholic Steatohepatitis (NASH) Market Size by Application
2.5.1 Nonalcoholic Steatohepatitis (NASH) Market Size CAGR by Application (2019 VS 2023 VS 2030)
2.5.2 Global Nonalcoholic Steatohepatitis (NASH) Market Size Market Share by Application (2019-2024)
3 NONALCOHOLIC STEATOHEPATITIS (NASH) MARKET SIZE BY PLAYER
3.1 Nonalcoholic Steatohepatitis (NASH) Market Size Market Share by Players
3.1.1 Global Nonalcoholic Steatohepatitis (NASH) Revenue by Players (2019-2024)
3.1.2 Global Nonalcoholic Steatohepatitis (NASH) Revenue Market Share by Players (2019-2024)
3.2 Global Nonalcoholic Steatohepatitis (NASH) Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2022-2024)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 NONALCOHOLIC STEATOHEPATITIS (NASH) BY REGIONS
4.1 Nonalcoholic Steatohepatitis (NASH) Market Size by Regions (2019-2024)
4.2 Americas Nonalcoholic Steatohepatitis (NASH) Market Size Growth (2019-2024)
4.3 APAC Nonalcoholic Steatohepatitis (NASH) Market Size Growth (2019-2024)
4.4 Europe Nonalcoholic Steatohepatitis (NASH) Market Size Growth (2019-2024)
4.5 Middle East & Africa Nonalcoholic Steatohepatitis (NASH) Market Size Growth (2019-2024)
5 AMERICAS
5.1 Americas Nonalcoholic Steatohepatitis (NASH) Market Size by Country (2019-2024)
5.2 Americas Nonalcoholic Steatohepatitis (NASH) Market Size by Type (2019-2024)
5.3 Americas Nonalcoholic Steatohepatitis (NASH) Market Size by Application (2019-2024)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Nonalcoholic Steatohepatitis (NASH) Market Size by Region (2019-2024)
6.2 APAC Nonalcoholic Steatohepatitis (NASH) Market Size by Type (2019-2024)
6.3 APAC Nonalcoholic Steatohepatitis (NASH) Market Size by Application (2019-2024)
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 EUROPE
7.1 Europe Nonalcoholic Steatohepatitis (NASH) by Country (2019-2024)
7.2 Europe Nonalcoholic Steatohepatitis (NASH) Market Size by Type (2019-2024)
7.3 Europe Nonalcoholic Steatohepatitis (NASH) Market Size by Application (2019-2024)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Nonalcoholic Steatohepatitis (NASH) by Region (2019-2024)
8.2 Middle East & Africa Nonalcoholic Steatohepatitis (NASH) Market Size by Type (2019-2024)
8.3 Middle East & Africa Nonalcoholic Steatohepatitis (NASH) Market Size by Application (2019-2024)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 GLOBAL NONALCOHOLIC STEATOHEPATITIS (NASH) MARKET FORECAST
10.1 Global Nonalcoholic Steatohepatitis (NASH) Forecast by Regions (2025-2030)
10.1.1 Global Nonalcoholic Steatohepatitis (NASH) Forecast by Regions (2025-2030)
10.1.2 Americas Nonalcoholic Steatohepatitis (NASH) Forecast
10.1.3 APAC Nonalcoholic Steatohepatitis (NASH) Forecast
10.1.4 Europe Nonalcoholic Steatohepatitis (NASH) Forecast
10.1.5 Middle East & Africa Nonalcoholic Steatohepatitis (NASH) Forecast
10.2 Americas Nonalcoholic Steatohepatitis (NASH) Forecast by Country (2025-2030)
10.2.1 United States Nonalcoholic Steatohepatitis (NASH) Market Forecast
10.2.2 Canada Nonalcoholic Steatohepatitis (NASH) Market Forecast
10.2.3 Mexico Nonalcoholic Steatohepatitis (NASH) Market Forecast
10.2.4 Brazil Nonalcoholic Steatohepatitis (NASH) Market Forecast
10.3 APAC Nonalcoholic Steatohepatitis (NASH) Forecast by Region (2025-2030)
10.3.1 China Nonalcoholic Steatohepatitis (NASH) Market Forecast
10.3.2 Japan Nonalcoholic Steatohepatitis (NASH) Market Forecast
10.3.3 Korea Nonalcoholic Steatohepatitis (NASH) Market Forecast
10.3.4 Southeast Asia Nonalcoholic Steatohepatitis (NASH) Market Forecast
10.3.5 India Nonalcoholic Steatohepatitis (NASH) Market Forecast
10.3.6 Australia Nonalcoholic Steatohepatitis (NASH) Market Forecast
10.4 Europe Nonalcoholic Steatohepatitis (NASH) Forecast by Country (2025-2030)
10.4.1 Germany Nonalcoholic Steatohepatitis (NASH) Market Forecast
10.4.2 France Nonalcoholic Steatohepatitis (NASH) Market Forecast
10.4.3 UK Nonalcoholic Steatohepatitis (NASH) Market Forecast
10.4.4 Italy Nonalcoholic Steatohepatitis (NASH) Market Forecast
10.4.5 Russia Nonalcoholic Steatohepatitis (NASH) Market Forecast
10.5 Middle East & Africa Nonalcoholic Steatohepatitis (NASH) Forecast by Region (2025-2030)
10.5.1 Egypt Nonalcoholic Steatohepatitis (NASH) Market Forecast
10.5.2 South Africa Nonalcoholic Steatohepatitis (NASH) Market Forecast
10.5.3 Israel Nonalcoholic Steatohepatitis (NASH) Market Forecast
10.5.4 Turkey Nonalcoholic Steatohepatitis (NASH) Market Forecast
10.5.5 GCC Countries Nonalcoholic Steatohepatitis (NASH) Market Forecast
10.6 Global Nonalcoholic Steatohepatitis (NASH) Forecast by Type (2025-2030)
10.7 Global Nonalcoholic Steatohepatitis (NASH) Forecast by Application (2025-2030)
11 KEY PLAYERS ANALYSIS
11.1 AstraZeneca
11.1.1 AstraZeneca Company Information
11.1.2 AstraZeneca Nonalcoholic Steatohepatitis (NASH) Product Offered
11.1.3 AstraZeneca Nonalcoholic Steatohepatitis (NASH) Revenue, Gross Margin and Market Share (2019-2024)
11.1.4 AstraZeneca Main Business Overview
11.1.5 AstraZeneca Latest Developments
11.2 Arena Pharmaceuticals
11.2.1 Arena Pharmaceuticals Company Information
11.2.2 Arena Pharmaceuticals Nonalcoholic Steatohepatitis (NASH) Product Offered
11.2.3 Arena Pharmaceuticals Nonalcoholic Steatohepatitis (NASH) Revenue, Gross Margin and Market Share (2019-2024)
11.2.4 Arena Pharmaceuticals Main Business Overview
11.2.5 Arena Pharmaceuticals Latest Developments
11.3 GSK
11.3.1 GSK Company Information
11.3.2 GSK Nonalcoholic Steatohepatitis (NASH) Product Offered
11.3.3 GSK Nonalcoholic Steatohepatitis (NASH) Revenue, Gross Margin and Market Share (2019-2024)
11.3.4 GSK Main Business Overview
11.3.5 GSK Latest Developments
11.4 Novo Nordisk
11.4.1 Novo Nordisk Company Information
11.4.2 Novo Nordisk Nonalcoholic Steatohepatitis (NASH) Product Offered
11.4.3 Novo Nordisk Nonalcoholic Steatohepatitis (NASH) Revenue, Gross Margin and Market Share (2019-2024)
11.4.4 Novo Nordisk Main Business Overview
11.4.5 Novo Nordisk Latest Developments
11.5 Roche
11.5.1 Roche Company Information
11.5.2 Roche Nonalcoholic Steatohepatitis (NASH) Product Offered
11.5.3 Roche Nonalcoholic Steatohepatitis (NASH) Revenue, Gross Margin and Market Share (2019-2024)
11.5.4 Roche Main Business Overview
11.5.5 Roche Latest Developments
11.6 Vivus
11.6.1 Vivus Company Information
11.6.2 Vivus Nonalcoholic Steatohepatitis (NASH) Product Offered
11.6.3 Vivus Nonalcoholic Steatohepatitis (NASH) Revenue, Gross Margin and Market Share (2019-2024)
11.6.4 Vivus Main Business Overview
11.6.5 Vivus Latest Developments
11.7 Arisaph Pharmaceuticals
11.7.1 Arisaph Pharmaceuticals Company Information
11.7.2 Arisaph Pharmaceuticals Nonalcoholic Steatohepatitis (NASH) Product Offered
11.7.3 Arisaph Pharmaceuticals Nonalcoholic Steatohepatitis (NASH) Revenue, Gross Margin and Market Share (2019-2024)
11.7.4 Arisaph Pharmaceuticals Main Business Overview
11.7.5 Arisaph Pharmaceuticals Latest Developments
11.8 Cempra Pharmaceuticals
11.8.1 Cempra Pharmaceuticals Company Information
11.8.2 Cempra Pharmaceuticals Nonalcoholic Steatohepatitis (NASH) Product Offered
11.8.3 Cempra Pharmaceuticals Nonalcoholic Steatohepatitis (NASH) Revenue, Gross Margin and Market Share (2019-2024)
11.8.4 Cempra Pharmaceuticals Main Business Overview
11.8.5 Cempra Pharmaceuticals Latest Developments
11.9 Galectin Therapeutics
11.9.1 Galectin Therapeutics Company Information
11.9.2 Galectin Therapeutics Nonalcoholic Steatohepatitis (NASH) Product Offered
11.9.3 Galectin Therapeutics Nonalcoholic Steatohepatitis (NASH) Revenue, Gross Margin and Market Share (2019-2024)
11.9.4 Galectin Therapeutics Main Business Overview
11.9.5 Galectin Therapeutics Latest Developments
11.10 Galmed Pharmaceuticals
11.10.1 Galmed Pharmaceuticals Company Information
11.10.2 Galmed Pharmaceuticals Nonalcoholic Steatohepatitis (NASH) Product Offered
11.10.3 Galmed Pharmaceuticals Nonalcoholic Steatohepatitis (NASH) Revenue, Gross Margin and Market Share (2019-2024)
11.10.4 Galmed Pharmaceuticals Main Business Overview
11.10.5 Galmed Pharmaceuticals Latest Developments
11.11 Genfit
11.11.1 Genfit Company Information
11.11.2 Genfit Nonalcoholic Steatohepatitis (NASH) Product Offered
11.11.3 Genfit Nonalcoholic Steatohepatitis (NASH) Revenue, Gross Margin and Market Share (2019-2024)
11.11.4 Genfit Main Business Overview
11.11.5 Genfit Latest Developments
11.12 Gilead
11.12.1 Gilead Company Information
11.12.2 Gilead Nonalcoholic Steatohepatitis (NASH) Product Offered
11.12.3 Gilead Nonalcoholic Steatohepatitis (NASH) Revenue, Gross Margin and Market Share (2019-2024)
11.12.4 Gilead Main Business Overview
11.12.5 Gilead Latest Developments
12 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES
Table 1. Nonalcoholic Steatohepatitis (NASH) Market Size CAGR by Region (2019 VS 2023 VS 2030) & ($ Millions)
Table 2. Major Players of Obeticholic acid?OCA?
Table 3. Major Players of Selonsertib
Table 4. Nonalcoholic Steatohepatitis (NASH) Market Size CAGR by Type (2019 VS 2023 VS 2030) & ($ Millions)
Table 5. Global Nonalcoholic Steatohepatitis (NASH) Market Size by Type (2019-2024) & ($ Millions)
Table 6. Global Nonalcoholic Steatohepatitis (NASH) Market Size Market Share by Type (2019-2024)
Table 7. Nonalcoholic Steatohepatitis (NASH) Market Size CAGR by Application (2019 VS 2023 VS 2030) & ($ Millions)
Table 8. Global Nonalcoholic Steatohepatitis (NASH) Market Size by Application (2019-2024) & ($ Millions)
Table 9. Global Nonalcoholic Steatohepatitis (NASH) Market Size Market Share by Application (2019-2024)
Table 10. Global Nonalcoholic Steatohepatitis (NASH) Revenue by Players (2019-2024) & ($ Millions)
Table 11. Global Nonalcoholic Steatohepatitis (NASH) Revenue Market Share by Player (2019-2024)
Table 12. Nonalcoholic Steatohepatitis (NASH) Key Players Head office and Products Offered
Table 13. Nonalcoholic Steatohepatitis (NASH) Concentration Ratio (CR3, CR5 and CR10) & (2022-2024)
Table 14. New Products and Potential Entrants
Table 15. Mergers & Acquisitions, Expansion
Table 16. Global Nonalcoholic Steatohepatitis (NASH) Market Size by Regions 2019-2024 & ($ Millions)
Table 17. Global Nonalcoholic Steatohepatitis (NASH) Market Size Market Share by Regions (2019-2024)
Table 18. Global Nonalcoholic Steatohepatitis (NASH) Revenue by Country/Region (2019-2024) & ($ millions)
Table 19. Global Nonalcoholic Steatohepatitis (NASH) Revenue Market Share by Country/Region (2019-2024)
Table 20. Americas Nonalcoholic Steatohepatitis (NASH) Market Size by Country (2019-2024) & ($ Millions)
Table 21. Americas Nonalcoholic Steatohepatitis (NASH) Market Size Market Share by Country (2019-2024)
Table 22. Americas Nonalcoholic Steatohepatitis (NASH) Market Size by Type (2019-2024) & ($ Millions)
Table 23. Americas Nonalcoholic Steatohepatitis (NASH) Market Size Market Share by Type (2019-2024)
Table 24. Americas Nonalcoholic Steatohepatitis (NASH) Market Size by Application (2019-2024) & ($ Millions)
Table 25. Americas Nonalcoholic Steatohepatitis (NASH) Market Size Market Share by Application (2019-2024)
Table 26. APAC Nonalcoholic Steatohepatitis (NASH) Market Size by Region (2019-2024) & ($ Millions)
Table 27. APAC Nonalcoholic Steatohepatitis (NASH) Market Size Market Share by Region (2019-2024)
Table 28. APAC Nonalcoholic Steatohepatitis (NASH) Market Size by Type (2019-2024) & ($ Millions)
Table 29. APAC Nonalcoholic Steatohepatitis (NASH) Market Size Market Share by Type (2019-2024)
Table 30. APAC Nonalcoholic Steatohepatitis (NASH) Market Size by Application (2019-2024) & ($ Millions)
Table 31. APAC Nonalcoholic Steatohepatitis (NASH) Market Size Market Share by Application (2019-2024)
Table 32. Europe Nonalcoholic Steatohepatitis (NASH) Market Size by Country (2019-2024) & ($ Millions)
Table 33. Europe Nonalcoholic Steatohepatitis (NASH) Market Size Market Share by Country (2019-2024)
Table 34. Europe Nonalcoholic Steatohepatitis (NASH) Market Size by Type (2019-2024) & ($ Millions)
Table 35. Europe Nonalcoholic Steatohepatitis (NASH) Market Size Market Share by Type (2019-2024)
Table 36. Europe Nonalcoholic Steatohepatitis (NASH) Market Size by Application (2019-2024) & ($ Millions)
Table 37. Europe Nonalcoholic Steatohepatitis (NASH) Market Size Market Share by Application (2019-2024)
Table 38. Middle East & Africa Nonalcoholic Steatohepatitis (NASH) Market Size by Region (2019-2024) & ($ Millions)
Table 39. Middle East & Africa Nonalcoholic Steatohepatitis (NASH) Market Size Market Share by Region (2019-2024)
Table 40. Middle East & Africa Nonalcoholic Steatohepatitis (NASH) Market Size by Type (2019-2024) & ($ Millions)
Table 41. Middle East & Africa Nonalcoholic Steatohepatitis (NASH) Market Size Market Share by Type (2019-2024)
Table 42. Middle East & Africa Nonalcoholic Steatohepatitis (NASH) Market Size by Application (2019-2024) & ($ Millions)
Table 43. Middle East & Africa Nonalcoholic Steatohepatitis (NASH) Market Size Market Share by Application (2019-2024)
Table 44. Key Market Drivers & Growth Opportunities of Nonalcoholic Steatohepatitis (NASH)
Table 45. Key Market Challenges & Risks of Nonalcoholic Steatohepatitis (NASH)
Table 46. Key Industry Trends of Nonalcoholic Steatohepatitis (NASH)
Table 47. Global Nonalcoholic Steatohepatitis (NASH) Market Size Forecast by Regions (2025-2030) & ($ Millions)
Table 48. Global Nonalcoholic Steatohepatitis (NASH) Market Size Market Share Forecast by Regions (2025-2030)
Table 49. Global Nonalcoholic Steatohepatitis (NASH) Market Size Forecast by Type (2025-2030) & ($ Millions)
Table 50. Global Nonalcoholic Steatohepatitis (NASH) Market Size Forecast by Application (2025-2030) & ($ Millions)
Table 51. AstraZeneca Details, Company Type, Nonalcoholic Steatohepatitis (NASH) Area Served and Its Competitors
Table 52. AstraZeneca Nonalcoholic Steatohepatitis (NASH) Product Offered
Table 53. AstraZeneca Nonalcoholic Steatohepatitis (NASH) Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 54. AstraZeneca Main Business
Table 55. AstraZeneca Latest Developments
Table 56. Arena Pharmaceuticals Details, Company Type, Nonalcoholic Steatohepatitis (NASH) Area Served and Its Competitors
Table 57. Arena Pharmaceuticals Nonalcoholic Steatohepatitis (NASH) Product Offered
Table 58. Arena Pharmaceuticals Main Business
Table 59. Arena Pharmaceuticals Nonalcoholic Steatohepatitis (NASH) Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 60. Arena Pharmaceuticals Latest Developments
Table 61. GSK Details, Company Type, Nonalcoholic Steatohepatitis (NASH) Area Served and Its Competitors
Table 62. GSK Nonalcoholic Steatohepatitis (NASH) Product Offered
Table 63. GSK Main Business
Table 64. GSK Nonalcoholic Steatohepatitis (NASH) Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 65. GSK Latest Developments
Table 66. Novo Nordisk Details, Company Type, Nonalcoholic Steatohepatitis (NASH) Area Served and Its Competitors
Table 67. Novo Nordisk Nonalcoholic Steatohepatitis (NASH) Product Offered
Table 68. Novo Nordisk Main Business
Table 69. Novo Nordisk Nonalcoholic Steatohepatitis (NASH) Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 70. Novo Nordisk Latest Developments
Table 71. Roche Details, Company Type, Nonalcoholic Steatohepatitis (NASH) Area Served and Its Competitors
Table 72. Roche Nonalcoholic Steatohepatitis (NASH) Product Offered
Table 73. Roche Main Business
Table 74. Roche Nonalcoholic Steatohepatitis (NASH) Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 75. Roche Latest Developments
Table 76. Vivus Details, Company Type, Nonalcoholic Steatohepatitis (NASH) Area Served and Its Competitors
Table 77. Vivus Nonalcoholic Steatohepatitis (NASH) Product Offered
Table 78. Vivus Main Business
Table 79. Vivus Nonalcoholic Steatohepatitis (NASH) Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 80. Vivus Latest Developments
Table 81. Arisaph Pharmaceuticals Details, Company Type, Nonalcoholic Steatohepatitis (NASH) Area Served and Its Competitors
Table 82. Arisaph Pharmaceuticals Nonalcoholic Steatohepatitis (NASH) Product Offered
Table 83. Arisaph Pharmaceuticals Main Business
Table 84. Arisaph Pharmaceuticals Nonalcoholic Steatohepatitis (NASH) Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 85. Arisaph Pharmaceuticals Latest Developments
Table 86. Cempra Pharmaceuticals Details, Company Type, Nonalcoholic Steatohepatitis (NASH) Area Served and Its Competitors
Table 87. Cempra Pharmaceuticals Nonalcoholic Steatohepatitis (NASH) Product Offered
Table 88. Cempra Pharmaceuticals Main Business
Table 89. Cempra Pharmaceuticals Nonalcoholic Steatohepatitis (NASH) Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 90. Cempra Pharmaceuticals Latest Developments
Table 91. Galectin Therapeutics Details, Company Type, Nonalcoholic Steatohepatitis (NASH) Area Served and Its Competitors
Table 92. Galectin Therapeutics Nonalcoholic Steatohepatitis (NASH) Product Offered
Table 93. Galectin Therapeutics Main Business
Table 94. Galectin Therapeutics Nonalcoholic Steatohepatitis (NASH) Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 95. Galectin Therapeutics Latest Developments
Table 96. Galmed Pharmaceuticals Details, Company Type, Nonalcoholic Steatohepatitis (NASH) Area Served and Its Competitors
Table 97. Galmed Pharmaceuticals Nonalcoholic Steatohepatitis (NASH) Product Offered
Table 98. Galmed Pharmaceuticals Main Business
Table 99. Galmed Pharmaceuticals Nonalcoholic Steatohepatitis (NASH) Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 100. Galmed Pharmaceuticals Latest Developments
Table 101. Genfit Details, Company Type, Nonalcoholic Steatohepatitis (NASH) Area Served and Its Competitors
Table 102. Genfit Nonalcoholic Steatohepatitis (NASH) Product Offered
Table 103. Genfit Nonalcoholic Steatohepatitis (NASH) Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 104. Genfit Main Business
Table 105. Genfit Latest Developments
Table 106. Gilead Details, Company Type, Nonalcoholic Steatohepatitis (NASH) Area Served and Its Competitors
Table 107. Gilead Nonalcoholic Steatohepatitis (NASH) Product Offered
Table 108. Gilead Main Business
Table 109. Gilead Nonalcoholic Steatohepatitis (NASH) Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 110. Gilead Latest Developments
Table 1. Nonalcoholic Steatohepatitis (NASH) Market Size CAGR by Region (2019 VS 2023 VS 2030) & ($ Millions)
Table 2. Major Players of Obeticholic acid?OCA?
Table 3. Major Players of Selonsertib
Table 4. Nonalcoholic Steatohepatitis (NASH) Market Size CAGR by Type (2019 VS 2023 VS 2030) & ($ Millions)
Table 5. Global Nonalcoholic Steatohepatitis (NASH) Market Size by Type (2019-2024) & ($ Millions)
Table 6. Global Nonalcoholic Steatohepatitis (NASH) Market Size Market Share by Type (2019-2024)
Table 7. Nonalcoholic Steatohepatitis (NASH) Market Size CAGR by Application (2019 VS 2023 VS 2030) & ($ Millions)
Table 8. Global Nonalcoholic Steatohepatitis (NASH) Market Size by Application (2019-2024) & ($ Millions)
Table 9. Global Nonalcoholic Steatohepatitis (NASH) Market Size Market Share by Application (2019-2024)
Table 10. Global Nonalcoholic Steatohepatitis (NASH) Revenue by Players (2019-2024) & ($ Millions)
Table 11. Global Nonalcoholic Steatohepatitis (NASH) Revenue Market Share by Player (2019-2024)
Table 12. Nonalcoholic Steatohepatitis (NASH) Key Players Head office and Products Offered
Table 13. Nonalcoholic Steatohepatitis (NASH) Concentration Ratio (CR3, CR5 and CR10) & (2022-2024)
Table 14. New Products and Potential Entrants
Table 15. Mergers & Acquisitions, Expansion
Table 16. Global Nonalcoholic Steatohepatitis (NASH) Market Size by Regions 2019-2024 & ($ Millions)
Table 17. Global Nonalcoholic Steatohepatitis (NASH) Market Size Market Share by Regions (2019-2024)
Table 18. Global Nonalcoholic Steatohepatitis (NASH) Revenue by Country/Region (2019-2024) & ($ millions)
Table 19. Global Nonalcoholic Steatohepatitis (NASH) Revenue Market Share by Country/Region (2019-2024)
Table 20. Americas Nonalcoholic Steatohepatitis (NASH) Market Size by Country (2019-2024) & ($ Millions)
Table 21. Americas Nonalcoholic Steatohepatitis (NASH) Market Size Market Share by Country (2019-2024)
Table 22. Americas Nonalcoholic Steatohepatitis (NASH) Market Size by Type (2019-2024) & ($ Millions)
Table 23. Americas Nonalcoholic Steatohepatitis (NASH) Market Size Market Share by Type (2019-2024)
Table 24. Americas Nonalcoholic Steatohepatitis (NASH) Market Size by Application (2019-2024) & ($ Millions)
Table 25. Americas Nonalcoholic Steatohepatitis (NASH) Market Size Market Share by Application (2019-2024)
Table 26. APAC Nonalcoholic Steatohepatitis (NASH) Market Size by Region (2019-2024) & ($ Millions)
Table 27. APAC Nonalcoholic Steatohepatitis (NASH) Market Size Market Share by Region (2019-2024)
Table 28. APAC Nonalcoholic Steatohepatitis (NASH) Market Size by Type (2019-2024) & ($ Millions)
Table 29. APAC Nonalcoholic Steatohepatitis (NASH) Market Size Market Share by Type (2019-2024)
Table 30. APAC Nonalcoholic Steatohepatitis (NASH) Market Size by Application (2019-2024) & ($ Millions)
Table 31. APAC Nonalcoholic Steatohepatitis (NASH) Market Size Market Share by Application (2019-2024)
Table 32. Europe Nonalcoholic Steatohepatitis (NASH) Market Size by Country (2019-2024) & ($ Millions)
Table 33. Europe Nonalcoholic Steatohepatitis (NASH) Market Size Market Share by Country (2019-2024)
Table 34. Europe Nonalcoholic Steatohepatitis (NASH) Market Size by Type (2019-2024) & ($ Millions)
Table 35. Europe Nonalcoholic Steatohepatitis (NASH) Market Size Market Share by Type (2019-2024)
Table 36. Europe Nonalcoholic Steatohepatitis (NASH) Market Size by Application (2019-2024) & ($ Millions)
Table 37. Europe Nonalcoholic Steatohepatitis (NASH) Market Size Market Share by Application (2019-2024)
Table 38. Middle East & Africa Nonalcoholic Steatohepatitis (NASH) Market Size by Region (2019-2024) & ($ Millions)
Table 39. Middle East & Africa Nonalcoholic Steatohepatitis (NASH) Market Size Market Share by Region (2019-2024)
Table 40. Middle East & Africa Nonalcoholic Steatohepatitis (NASH) Market Size by Type (2019-2024) & ($ Millions)
Table 41. Middle East & Africa Nonalcoholic Steatohepatitis (NASH) Market Size Market Share by Type (2019-2024)
Table 42. Middle East & Africa Nonalcoholic Steatohepatitis (NASH) Market Size by Application (2019-2024) & ($ Millions)
Table 43. Middle East & Africa Nonalcoholic Steatohepatitis (NASH) Market Size Market Share by Application (2019-2024)
Table 44. Key Market Drivers & Growth Opportunities of Nonalcoholic Steatohepatitis (NASH)
Table 45. Key Market Challenges & Risks of Nonalcoholic Steatohepatitis (NASH)
Table 46. Key Industry Trends of Nonalcoholic Steatohepatitis (NASH)
Table 47. Global Nonalcoholic Steatohepatitis (NASH) Market Size Forecast by Regions (2025-2030) & ($ Millions)
Table 48. Global Nonalcoholic Steatohepatitis (NASH) Market Size Market Share Forecast by Regions (2025-2030)
Table 49. Global Nonalcoholic Steatohepatitis (NASH) Market Size Forecast by Type (2025-2030) & ($ Millions)
Table 50. Global Nonalcoholic Steatohepatitis (NASH) Market Size Forecast by Application (2025-2030) & ($ Millions)
Table 51. AstraZeneca Details, Company Type, Nonalcoholic Steatohepatitis (NASH) Area Served and Its Competitors
Table 52. AstraZeneca Nonalcoholic Steatohepatitis (NASH) Product Offered
Table 53. AstraZeneca Nonalcoholic Steatohepatitis (NASH) Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 54. AstraZeneca Main Business
Table 55. AstraZeneca Latest Developments
Table 56. Arena Pharmaceuticals Details, Company Type, Nonalcoholic Steatohepatitis (NASH) Area Served and Its Competitors
Table 57. Arena Pharmaceuticals Nonalcoholic Steatohepatitis (NASH) Product Offered
Table 58. Arena Pharmaceuticals Main Business
Table 59. Arena Pharmaceuticals Nonalcoholic Steatohepatitis (NASH) Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 60. Arena Pharmaceuticals Latest Developments
Table 61. GSK Details, Company Type, Nonalcoholic Steatohepatitis (NASH) Area Served and Its Competitors
Table 62. GSK Nonalcoholic Steatohepatitis (NASH) Product Offered
Table 63. GSK Main Business
Table 64. GSK Nonalcoholic Steatohepatitis (NASH) Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 65. GSK Latest Developments
Table 66. Novo Nordisk Details, Company Type, Nonalcoholic Steatohepatitis (NASH) Area Served and Its Competitors
Table 67. Novo Nordisk Nonalcoholic Steatohepatitis (NASH) Product Offered
Table 68. Novo Nordisk Main Business
Table 69. Novo Nordisk Nonalcoholic Steatohepatitis (NASH) Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 70. Novo Nordisk Latest Developments
Table 71. Roche Details, Company Type, Nonalcoholic Steatohepatitis (NASH) Area Served and Its Competitors
Table 72. Roche Nonalcoholic Steatohepatitis (NASH) Product Offered
Table 73. Roche Main Business
Table 74. Roche Nonalcoholic Steatohepatitis (NASH) Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 75. Roche Latest Developments
Table 76. Vivus Details, Company Type, Nonalcoholic Steatohepatitis (NASH) Area Served and Its Competitors
Table 77. Vivus Nonalcoholic Steatohepatitis (NASH) Product Offered
Table 78. Vivus Main Business
Table 79. Vivus Nonalcoholic Steatohepatitis (NASH) Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 80. Vivus Latest Developments
Table 81. Arisaph Pharmaceuticals Details, Company Type, Nonalcoholic Steatohepatitis (NASH) Area Served and Its Competitors
Table 82. Arisaph Pharmaceuticals Nonalcoholic Steatohepatitis (NASH) Product Offered
Table 83. Arisaph Pharmaceuticals Main Business
Table 84. Arisaph Pharmaceuticals Nonalcoholic Steatohepatitis (NASH) Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 85. Arisaph Pharmaceuticals Latest Developments
Table 86. Cempra Pharmaceuticals Details, Company Type, Nonalcoholic Steatohepatitis (NASH) Area Served and Its Competitors
Table 87. Cempra Pharmaceuticals Nonalcoholic Steatohepatitis (NASH) Product Offered
Table 88. Cempra Pharmaceuticals Main Business
Table 89. Cempra Pharmaceuticals Nonalcoholic Steatohepatitis (NASH) Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 90. Cempra Pharmaceuticals Latest Developments
Table 91. Galectin Therapeutics Details, Company Type, Nonalcoholic Steatohepatitis (NASH) Area Served and Its Competitors
Table 92. Galectin Therapeutics Nonalcoholic Steatohepatitis (NASH) Product Offered
Table 93. Galectin Therapeutics Main Business
Table 94. Galectin Therapeutics Nonalcoholic Steatohepatitis (NASH) Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 95. Galectin Therapeutics Latest Developments
Table 96. Galmed Pharmaceuticals Details, Company Type, Nonalcoholic Steatohepatitis (NASH) Area Served and Its Competitors
Table 97. Galmed Pharmaceuticals Nonalcoholic Steatohepatitis (NASH) Product Offered
Table 98. Galmed Pharmaceuticals Main Business
Table 99. Galmed Pharmaceuticals Nonalcoholic Steatohepatitis (NASH) Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 100. Galmed Pharmaceuticals Latest Developments
Table 101. Genfit Details, Company Type, Nonalcoholic Steatohepatitis (NASH) Area Served and Its Competitors
Table 102. Genfit Nonalcoholic Steatohepatitis (NASH) Product Offered
Table 103. Genfit Nonalcoholic Steatohepatitis (NASH) Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 104. Genfit Main Business
Table 105. Genfit Latest Developments
Table 106. Gilead Details, Company Type, Nonalcoholic Steatohepatitis (NASH) Area Served and Its Competitors
Table 107. Gilead Nonalcoholic Steatohepatitis (NASH) Product Offered
Table 108. Gilead Main Business
Table 109. Gilead Nonalcoholic Steatohepatitis (NASH) Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 110. Gilead Latest Developments
LIST OF FIGURES
Figure 1. Nonalcoholic Steatohepatitis (NASH) Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Nonalcoholic Steatohepatitis (NASH) Market Size Growth Rate 2019-2030 ($ Millions)
Figure 6. Nonalcoholic Steatohepatitis (NASH) Sales by Geographic Region (2019, 2023 & 2030) & ($ millions)
Figure 7. Nonalcoholic Steatohepatitis (NASH) Sales Market Share by Country/Region (2023)
Figure 8. Nonalcoholic Steatohepatitis (NASH) Sales Market Share by Country/Region (2019, 2023 & 2030)
Figure 9. Global Nonalcoholic Steatohepatitis (NASH) Market Size Market Share by Type in 2023
Figure 10. Nonalcoholic Steatohepatitis (NASH) in Hospital Pharmacy
Figure 11. Global Nonalcoholic Steatohepatitis (NASH) Market: Hospital Pharmacy (2019-2024) & ($ Millions)
Figure 12. Nonalcoholic Steatohepatitis (NASH) in Online Provider
Figure 13. Global Nonalcoholic Steatohepatitis (NASH) Market: Online Provider (2019-2024) & ($ Millions)
Figure 14. Nonalcoholic Steatohepatitis (NASH) in Retail Pharmacy
Figure 15. Global Nonalcoholic Steatohepatitis (NASH) Market: Retail Pharmacy (2019-2024) & ($ Millions)
Figure 16. Global Nonalcoholic Steatohepatitis (NASH) Market Size Market Share by Application in 2023
Figure 17. Global Nonalcoholic Steatohepatitis (NASH) Revenue Market Share by Player in 2023
Figure 18. Global Nonalcoholic Steatohepatitis (NASH) Market Size Market Share by Regions (2019-2024)
Figure 19. Americas Nonalcoholic Steatohepatitis (NASH) Market Size 2019-2024 ($ Millions)
Figure 20. APAC Nonalcoholic Steatohepatitis (NASH) Market Size 2019-2024 ($ Millions)
Figure 21. Europe Nonalcoholic Steatohepatitis (NASH) Market Size 2019-2024 ($ Millions)
Figure 22. Middle East & Africa Nonalcoholic Steatohepatitis (NASH) Market Size 2019-2024 ($ Millions)
Figure 23. Americas Nonalcoholic Steatohepatitis (NASH) Value Market Share by Country in 2023
Figure 24. United States Nonalcoholic Steatohepatitis (NASH) Market Size Growth 2019-2024 ($ Millions)
Figure 25. Canada Nonalcoholic Steatohepatitis (NASH) Market Size Growth 2019-2024 ($ Millions)
Figure 26. Mexico Nonalcoholic Steatohepatitis (NASH) Market Size Growth 2019-2024 ($ Millions)
Figure 27. Brazil Nonalcoholic Steatohepatitis (NASH) Market Size Growth 2019-2024 ($ Millions)
Figure 28. APAC Nonalcoholic Steatohepatitis (NASH) Market Size Market Share by Region in 2023
Figure 29. APAC Nonalcoholic Steatohepatitis (NASH) Market Size Market Share by Type in 2023
Figure 30. APAC Nonalcoholic Steatohepatitis (NASH) Market Size Market Share by Application in 2023
Figure 31. China Nonalcoholic Steatohepatitis (NASH) Market Size Growth 2019-2024 ($ Millions)
Figure 32. Japan Nonalcoholic Steatohepatitis (NASH) Market Size Growth 2019-2024 ($ Millions)
Figure 33. Korea Nonalcoholic Steatohepatitis (NASH) Market Size Growth 2019-2024 ($ Millions)
Figure 34. Southeast Asia Nonalcoholic Steatohepatitis (NASH) Market Size Growth 2019-2024 ($ Millions)
Figure 35. India Nonalcoholic Steatohepatitis (NASH) Market Size Growth 2019-2024 ($ Millions)
Figure 36. Australia Nonalcoholic Steatohepatitis (NASH) Market Size Growth 2019-2024 ($ Millions)
Figure 37. Europe Nonalcoholic Steatohepatitis (NASH) Market Size Market Share by Country in 2023
Figure 38. Europe Nonalcoholic Steatohepatitis (NASH) Market Size Market Share by Type (2019-2024)
Figure 39. Europe Nonalcoholic Steatohepatitis (NASH) Market Size Market Share by Application (2019-2024)
Figure 40. Germany Nonalcoholic Steatohepatitis (NASH) Market Size Growth 2019-2024 ($ Millions)
Figure 41. France Nonalcoholic Steatohepatitis (NASH) Market Size Growth 2019-2024 ($ Millions)
Figure 42. UK Nonalcoholic Steatohepatitis (NASH) Market Size Growth 2019-2024 ($ Millions)
Figure 43. Italy Nonalcoholic Steatohepatitis (NASH) Market Size Growth 2019-2024 ($ Millions)
Figure 44. Russia Nonalcoholic Steatohepatitis (NASH) Market Size Growth 2019-2024 ($ Millions)
Figure 45. Middle East & Africa Nonalcoholic Steatohepatitis (NASH) Market Size Market Share by Region (2019-2024)
Figure 46. Middle East & Africa Nonalcoholic Steatohepatitis (NASH) Market Size Market Share by Type (2019-2024)
Figure 47. Middle East & Africa Nonalcoholic Steatohepatitis (NASH) Market Size Market Share by Application (2019-2024)
Figure 48. Egypt Nonalcoholic Steatohepatitis (NASH) Market Size Growth 2019-2024 ($ Millions)
Figure 49. South Africa Nonalcoholic Steatohepatitis (NASH) Market Size Growth 2019-2024 ($ Millions)
Figure 50. Israel Nonalcoholic Steatohepatitis (NASH) Market Size Growth 2019-2024 ($ Millions)
Figure 51. Turkey Nonalcoholic Steatohepatitis (NASH) Market Size Growth 2019-2024 ($ Millions)
Figure 52. GCC Country Nonalcoholic Steatohepatitis (NASH) Market Size Growth 2019-2024 ($ Millions)
Figure 53. Americas Nonalcoholic Steatohepatitis (NASH) Market Size 2025-2030 ($ Millions)
Figure 54. APAC Nonalcoholic Steatohepatitis (NASH) Market Size 2025-2030 ($ Millions)
Figure 55. Europe Nonalcoholic Steatohepatitis (NASH) Market Size 2025-2030 ($ Millions)
Figure 56. Middle East & Africa Nonalcoholic Steatohepatitis (NASH) Market Size 2025-2030 ($ Millions)
Figure 57. United States Nonalcoholic Steatohepatitis (NASH) Market Size 2025-2030 ($ Millions)
Figure 58. Canada Nonalcoholic Steatohepatitis (NASH) Market Size 2025-2030 ($ Millions)
Figure 59. Mexico Nonalcoholic Steatohepatitis (NASH) Market Size 2025-2030 ($ Millions)
Figure 60. Brazil Nonalcoholic Steatohepatitis (NASH) Market Size 2025-2030 ($ Millions)
Figure 61. China Nonalcoholic Steatohepatitis (NASH) Market Size 2025-2030 ($ Millions)
Figure 62. Japan Nonalcoholic Steatohepatitis (NASH) Market Size 2025-2030 ($ Millions)
Figure 63. Korea Nonalcoholic Steatohepatitis (NASH) Market Size 2025-2030 ($ Millions)
Figure 64. Southeast Asia Nonalcoholic Steatohepatitis (NASH) Market Size 2025-2030 ($ Millions)
Figure 65. India Nonalcoholic Steatohepatitis (NASH) Market Size 2025-2030 ($ Millions)
Figure 66. Australia Nonalcoholic Steatohepatitis (NASH) Market Size 2025-2030 ($ Millions)
Figure 67. Germany Nonalcoholic Steatohepatitis (NASH) Market Size 2025-2030 ($ Millions)
Figure 68. France Nonalcoholic Steatohepatitis (NASH) Market Size 2025-2030 ($ Millions)
Figure 69. UK Nonalcoholic Steatohepatitis (NASH) Market Size 2025-2030 ($ Millions)
Figure 70. Italy Nonalcoholic Steatohepatitis (NASH) Market Size 2025-2030 ($ Millions)
Figure 71. Russia Nonalcoholic Steatohepatitis (NASH) Market Size 2025-2030 ($ Millions)
Figure 72. Spain Nonalcoholic Steatohepatitis (NASH) Market Size 2025-2030 ($ Millions)
Figure 73. Egypt Nonalcoholic Steatohepatitis (NASH) Market Size 2025-2030 ($ Millions)
Figure 74. South Africa Nonalcoholic Steatohepatitis (NASH) Market Size 2025-2030 ($ Millions)
Figure 75. Israel Nonalcoholic Steatohepatitis (NASH) Market Size 2025-2030 ($ Millions)
Figure 76. Turkey Nonalcoholic Steatohepatitis (NASH) Market Size 2025-2030 ($ Millions)
Figure 77. GCC Countries Nonalcoholic Steatohepatitis (NASH) Market Size 2025-2030 ($ Millions)
Figure 78. Global Nonalcoholic Steatohepatitis (NASH) Market Size Market Share Forecast by Type (2025-2030)
Figure 79. Global Nonalcoholic Steatohepatitis (NASH) Market Size Market Share Forecast by Application (2025-2030)
Figure 1. Nonalcoholic Steatohepatitis (NASH) Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Nonalcoholic Steatohepatitis (NASH) Market Size Growth Rate 2019-2030 ($ Millions)
Figure 6. Nonalcoholic Steatohepatitis (NASH) Sales by Geographic Region (2019, 2023 & 2030) & ($ millions)
Figure 7. Nonalcoholic Steatohepatitis (NASH) Sales Market Share by Country/Region (2023)
Figure 8. Nonalcoholic Steatohepatitis (NASH) Sales Market Share by Country/Region (2019, 2023 & 2030)
Figure 9. Global Nonalcoholic Steatohepatitis (NASH) Market Size Market Share by Type in 2023
Figure 10. Nonalcoholic Steatohepatitis (NASH) in Hospital Pharmacy
Figure 11. Global Nonalcoholic Steatohepatitis (NASH) Market: Hospital Pharmacy (2019-2024) & ($ Millions)
Figure 12. Nonalcoholic Steatohepatitis (NASH) in Online Provider
Figure 13. Global Nonalcoholic Steatohepatitis (NASH) Market: Online Provider (2019-2024) & ($ Millions)
Figure 14. Nonalcoholic Steatohepatitis (NASH) in Retail Pharmacy
Figure 15. Global Nonalcoholic Steatohepatitis (NASH) Market: Retail Pharmacy (2019-2024) & ($ Millions)
Figure 16. Global Nonalcoholic Steatohepatitis (NASH) Market Size Market Share by Application in 2023
Figure 17. Global Nonalcoholic Steatohepatitis (NASH) Revenue Market Share by Player in 2023
Figure 18. Global Nonalcoholic Steatohepatitis (NASH) Market Size Market Share by Regions (2019-2024)
Figure 19. Americas Nonalcoholic Steatohepatitis (NASH) Market Size 2019-2024 ($ Millions)
Figure 20. APAC Nonalcoholic Steatohepatitis (NASH) Market Size 2019-2024 ($ Millions)
Figure 21. Europe Nonalcoholic Steatohepatitis (NASH) Market Size 2019-2024 ($ Millions)
Figure 22. Middle East & Africa Nonalcoholic Steatohepatitis (NASH) Market Size 2019-2024 ($ Millions)
Figure 23. Americas Nonalcoholic Steatohepatitis (NASH) Value Market Share by Country in 2023
Figure 24. United States Nonalcoholic Steatohepatitis (NASH) Market Size Growth 2019-2024 ($ Millions)
Figure 25. Canada Nonalcoholic Steatohepatitis (NASH) Market Size Growth 2019-2024 ($ Millions)
Figure 26. Mexico Nonalcoholic Steatohepatitis (NASH) Market Size Growth 2019-2024 ($ Millions)
Figure 27. Brazil Nonalcoholic Steatohepatitis (NASH) Market Size Growth 2019-2024 ($ Millions)
Figure 28. APAC Nonalcoholic Steatohepatitis (NASH) Market Size Market Share by Region in 2023
Figure 29. APAC Nonalcoholic Steatohepatitis (NASH) Market Size Market Share by Type in 2023
Figure 30. APAC Nonalcoholic Steatohepatitis (NASH) Market Size Market Share by Application in 2023
Figure 31. China Nonalcoholic Steatohepatitis (NASH) Market Size Growth 2019-2024 ($ Millions)
Figure 32. Japan Nonalcoholic Steatohepatitis (NASH) Market Size Growth 2019-2024 ($ Millions)
Figure 33. Korea Nonalcoholic Steatohepatitis (NASH) Market Size Growth 2019-2024 ($ Millions)
Figure 34. Southeast Asia Nonalcoholic Steatohepatitis (NASH) Market Size Growth 2019-2024 ($ Millions)
Figure 35. India Nonalcoholic Steatohepatitis (NASH) Market Size Growth 2019-2024 ($ Millions)
Figure 36. Australia Nonalcoholic Steatohepatitis (NASH) Market Size Growth 2019-2024 ($ Millions)
Figure 37. Europe Nonalcoholic Steatohepatitis (NASH) Market Size Market Share by Country in 2023
Figure 38. Europe Nonalcoholic Steatohepatitis (NASH) Market Size Market Share by Type (2019-2024)
Figure 39. Europe Nonalcoholic Steatohepatitis (NASH) Market Size Market Share by Application (2019-2024)
Figure 40. Germany Nonalcoholic Steatohepatitis (NASH) Market Size Growth 2019-2024 ($ Millions)
Figure 41. France Nonalcoholic Steatohepatitis (NASH) Market Size Growth 2019-2024 ($ Millions)
Figure 42. UK Nonalcoholic Steatohepatitis (NASH) Market Size Growth 2019-2024 ($ Millions)
Figure 43. Italy Nonalcoholic Steatohepatitis (NASH) Market Size Growth 2019-2024 ($ Millions)
Figure 44. Russia Nonalcoholic Steatohepatitis (NASH) Market Size Growth 2019-2024 ($ Millions)
Figure 45. Middle East & Africa Nonalcoholic Steatohepatitis (NASH) Market Size Market Share by Region (2019-2024)
Figure 46. Middle East & Africa Nonalcoholic Steatohepatitis (NASH) Market Size Market Share by Type (2019-2024)
Figure 47. Middle East & Africa Nonalcoholic Steatohepatitis (NASH) Market Size Market Share by Application (2019-2024)
Figure 48. Egypt Nonalcoholic Steatohepatitis (NASH) Market Size Growth 2019-2024 ($ Millions)
Figure 49. South Africa Nonalcoholic Steatohepatitis (NASH) Market Size Growth 2019-2024 ($ Millions)
Figure 50. Israel Nonalcoholic Steatohepatitis (NASH) Market Size Growth 2019-2024 ($ Millions)
Figure 51. Turkey Nonalcoholic Steatohepatitis (NASH) Market Size Growth 2019-2024 ($ Millions)
Figure 52. GCC Country Nonalcoholic Steatohepatitis (NASH) Market Size Growth 2019-2024 ($ Millions)
Figure 53. Americas Nonalcoholic Steatohepatitis (NASH) Market Size 2025-2030 ($ Millions)
Figure 54. APAC Nonalcoholic Steatohepatitis (NASH) Market Size 2025-2030 ($ Millions)
Figure 55. Europe Nonalcoholic Steatohepatitis (NASH) Market Size 2025-2030 ($ Millions)
Figure 56. Middle East & Africa Nonalcoholic Steatohepatitis (NASH) Market Size 2025-2030 ($ Millions)
Figure 57. United States Nonalcoholic Steatohepatitis (NASH) Market Size 2025-2030 ($ Millions)
Figure 58. Canada Nonalcoholic Steatohepatitis (NASH) Market Size 2025-2030 ($ Millions)
Figure 59. Mexico Nonalcoholic Steatohepatitis (NASH) Market Size 2025-2030 ($ Millions)
Figure 60. Brazil Nonalcoholic Steatohepatitis (NASH) Market Size 2025-2030 ($ Millions)
Figure 61. China Nonalcoholic Steatohepatitis (NASH) Market Size 2025-2030 ($ Millions)
Figure 62. Japan Nonalcoholic Steatohepatitis (NASH) Market Size 2025-2030 ($ Millions)
Figure 63. Korea Nonalcoholic Steatohepatitis (NASH) Market Size 2025-2030 ($ Millions)
Figure 64. Southeast Asia Nonalcoholic Steatohepatitis (NASH) Market Size 2025-2030 ($ Millions)
Figure 65. India Nonalcoholic Steatohepatitis (NASH) Market Size 2025-2030 ($ Millions)
Figure 66. Australia Nonalcoholic Steatohepatitis (NASH) Market Size 2025-2030 ($ Millions)
Figure 67. Germany Nonalcoholic Steatohepatitis (NASH) Market Size 2025-2030 ($ Millions)
Figure 68. France Nonalcoholic Steatohepatitis (NASH) Market Size 2025-2030 ($ Millions)
Figure 69. UK Nonalcoholic Steatohepatitis (NASH) Market Size 2025-2030 ($ Millions)
Figure 70. Italy Nonalcoholic Steatohepatitis (NASH) Market Size 2025-2030 ($ Millions)
Figure 71. Russia Nonalcoholic Steatohepatitis (NASH) Market Size 2025-2030 ($ Millions)
Figure 72. Spain Nonalcoholic Steatohepatitis (NASH) Market Size 2025-2030 ($ Millions)
Figure 73. Egypt Nonalcoholic Steatohepatitis (NASH) Market Size 2025-2030 ($ Millions)
Figure 74. South Africa Nonalcoholic Steatohepatitis (NASH) Market Size 2025-2030 ($ Millions)
Figure 75. Israel Nonalcoholic Steatohepatitis (NASH) Market Size 2025-2030 ($ Millions)
Figure 76. Turkey Nonalcoholic Steatohepatitis (NASH) Market Size 2025-2030 ($ Millions)
Figure 77. GCC Countries Nonalcoholic Steatohepatitis (NASH) Market Size 2025-2030 ($ Millions)
Figure 78. Global Nonalcoholic Steatohepatitis (NASH) Market Size Market Share Forecast by Type (2025-2030)
Figure 79. Global Nonalcoholic Steatohepatitis (NASH) Market Size Market Share Forecast by Application (2025-2030)
More Publications
Global Oxygen Supply System to Hospitals Market Growth (Status and Outlook) 2025-2031
US$ 3,660.00
April 2025
101 pages
Global Adult Spinal Deformity Market Growth (Status and Outlook) 2024-2030
US$ 3,660.00
October 2024
101 pages
Global Physiological Monitors Market Growth 2023-2029
US$ 3,660.00
February 2023
109 pages
Global Varicella Virus Vaccine Market Growth 2024-2030
US$ 3,660.00
March 2024
92 pages
Global 3D Hip and Knee Implant Market Growth 2024-2030
US$ 3,660.00
June 2024
95 pages
